Scarica l'app Stockscreener
1.78
0.00%
0.00
Dopo l'orario di chiusura:
1.79
0.01
+0.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.78
Aprire:
$1.78
Volume 24 ore:
1.59M
Relative Volume:
0.61
Capitalizzazione di mercato:
$187.43M
Reddito:
-
Utile/perdita netta:
$-37.34M
Rapporto P/E:
-1.3088
EPS:
-1.36
Flusso di cassa netto:
$-36.91M
1 W Prestazione:
-7.29%
1M Prestazione:
+11.95%
6M Prestazione:
+50.85%
1 anno Prestazione:
+44.72%
Intervallo 1D:
$1.75
$1.82
Intervallo di 1 settimana:
$1.75
$1.96
Portata 52W:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Nome
Sellas Life Sciences Group Inc
Settore
Industria
Telefono
(646) 200-5278
Indirizzo
7 TIMES SQUARE, NEW YORK, NY
Confronta SLS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.78 | 192.69M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Iniziato | Oppenheimer | Outperform |
| 2018-04-02 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Aggiornamento | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
Real time alert setup for SELLAS Life Sciences Group Inc. performanceQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Should you hold or exit SELLAS Life Sciences Group Inc. nowJuly 2025 Closing Moves & Precise Buy Zone Tips - Newser
What’s next for SELLAS Life Sciences Group Inc. stock priceJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Should value investors consider SELLAS Life Sciences Group Inc.2025 Bull vs Bear & Detailed Earnings Play Strategies - khodrobank.com
Sentiment analysis tools applied to SELLAS Life Sciences Group Inc.Market Growth Summary & Stock Portfolio Risk Control - Newser
Real time breakdown of SELLAS Life Sciences Group Inc. stock performanceJuly 2025 WrapUp & Long-Term Safe Return Strategies - Newser
What earnings revisions data tells us about SELLAS Life Sciences Group Inc.July 2025 Fed Impact & Community Shared Stock Ideas - Newser
What does recent volatility data suggest for SELLAS Life Sciences Group Inc.2025 Pullback Review & Low Risk Growth Stock Ideas - Newser
What dividend growth rate does SELLAS Life Sciences Group Inc. offerJuly 2025 Review & Verified Trade Idea Suggestions - khodrobank.com
What MACD signals say about SELLAS Life Sciences Group Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
How much upside does SELLAS Life Sciences Group Inc. haveMarket Activity Report & Verified Entry Point Detection - khodrobank.com
Intraday Charts Show Spike in SELLAS Life Sciences Group Inc. Activity2025 Fundamental Recap & Consistent Income Trade Recommendations - beatles.ru
Does SELLAS Life Sciences Group Inc. stock benefit from AI growthMarket Volume Report & Free Real-Time Market Sentiment Alerts - khodrobank.com
Is SELLAS Life Sciences Group Inc. stock heavily shortedMarket Growth Summary & Safe Entry Momentum Tips - khodrobank.com
Building trade automation scripts for SELLAS Life Sciences Group Inc.Quarterly Profit Review & Expert Approved Momentum Ideas - Newser
What makes SELLAS Life Sciences Group Inc. stock attractive to long term investors2025 Price Action Summary & Safe Entry Trade Reports - Newser
What’s the fair value of SELLAS Life Sciences Group Inc. stockJuly 2025 Trends & Growth Focused Stock Pick Reports - khodrobank.com
Automated trading signals detected on SELLAS Life Sciences Group Inc.Weekly Gains Report & Real-Time Market Sentiment Alerts - Newser
How to forecast SELLAS Life Sciences Group Inc. trends using time series2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Will SELLAS Life Sciences Group Inc. Hold Gains Into Close getLinesFromResByArray error: size == 0 - thegnnews.com
Is SELLAS Life Sciences Group Inc. forming a bottoming baseTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
SELLAS Life Sciences Group Inc. Breaks Below Key Support Level getLinesFromResByArray error: size == 0 - kangso.co.kr
Trend analysis for SELLAS Life Sciences Group Inc. this weekQuarterly Profit Report & Capital Efficiency Focused Strategies - Newser
Can SELLAS Life Sciences Group Inc. maintain its current growth rateQuarterly Growth Report & Short-Term High Return Ideas - sundaytimes.kr
Published on: 2025-09-02 23:33:47 - Newser
How hedge fund analytics apply to BURU stockGap Up & Safe Entry Trade Signal Reports - Newser
Is SELLAS Life Sciences Group Inc. stock reversal real or fakeEarnings Risk Report & Safe Swing Trade Setup Alerts - Newser
Is CREX reversing from oversold territoryPortfolio Risk Summary & Real-Time Sentiment Analysis - Newser
Is KWESW stock reversal real or fakeJuly 2025 Volume & Smart Investment Allocation Insights - Newser
SELLAS Life Sciences Group Inc. stock daily chart insightsPortfolio Growth Summary & Expert Approved Momentum Ideas - Newser
Price action breakdown for SELLAS Life Sciences Group Inc.Analyst Upgrade & Community Supported Trade Ideas - Newser
Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sellas Life Sciences Group Inc Azioni (SLS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wasman Jane | Director |
May 30 '25 |
Buy |
1.69 |
20,000 |
33,800 |
30,400 |
| Kalin Katherine Bach | Director |
May 22 '25 |
Buy |
1.80 |
20,000 |
36,000 |
41,000 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):